{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:16:50Z","timestamp":1788283010155,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajo.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:53:44Z","timestamp":1781312024000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Microperimetry as an Outcome Measure Improves Patient Eligibility and Efficacy Detection in RPGR Gene Therapy Trials"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1808-6546","authenticated-orcid":false,"given":"AMANDEEP SINGH","family":"JOSAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LAURA J.","family":"TAYLOR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHABNAM","family":"RAJI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JASMINA","family":"CEHAJIC-KAPETANOVIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT E.","family":"MACLAREN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2026.06.002_bib0001","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog Retinal Eye Res"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.002_bib0002","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0161-6420(98)96009-2","article-title":"Patterns of visual field progression in patients with retinitis pigmentosa","volume":"105","author":"Grover","year":"1998","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.11.5.15","article-title":"Characterizing visual fields in RPGR related retinitis pigmentosa using Octopus static-automated perimetry","volume":"11","author":"Buckley","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.002_bib0004","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1167\/iovs.02-1206","article-title":"RPGR isoforms in photoreceptor connecting cilia and the transitional zone of motile cilia","volume":"44","author":"Hong","year":"2003","journal-title":"Investigat Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.002_bib0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/hmg\/ddw017","article-title":"Loss of human disease protein retinitis pigmentosa GTPase regulator (RPGR) differentially affects rod or cone-enriched retina","volume":"25","author":"Rao","year":"2016","journal-title":"Human Mol Genet"},{"key":"10.1016\/j.ajo.2026.06.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100907","article-title":"Fundus-controlled perimetry (microperimetry): application as outcome measure in clinical trials","volume":"82","author":"Pfau","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.12.6.4","article-title":"Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials","volume":"12","author":"Taylor","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.002_bib0008","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","article-title":"Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR","volume":"26","author":"Cehajic-Kapetanovic","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ajo.2026.06.002_bib0009","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/17469899.2025.2487544","article-title":"Approval of retinal gene therapies in the US and Europe based on visual acuity and microperimetry","volume":"20","author":"Josan","year":"2025","journal-title":"Exp Rev Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.002_bib0010","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/opo.13504","article-title":"Exploring standard and low luminance visual acuity and the moorfields acuity chart as outcome measures in inherited retinal disease","volume":"45","author":"Taylor","year":"2025","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.002_bib0011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/opo.12775","article-title":"Low luminance visual acuity as a clinical measure and clinical trial outcome measure: a scoping review","volume":"41","author":"Wood","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.002_bib0012","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.14.8.37","article-title":"Addressing challenges in developing treatments for inherited retinal diseases: recommendations from the third monaciano symposium","volume":"14","author":"Thompson","year":"2025","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2026.06.002_bib0013","unstructured":"FDA guidelines. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/neovascular-age-related-macular-degeneration-developing-drugs-treatment."},{"key":"10.1016\/j.ajo.2026.06.002_bib0014","unstructured":"Beacon Ema endpoint. https:\/\/euclinicaltrials.eu\/ctis-public\/view\/2024-511181-36-00?lang=en."},{"issue":"9","key":"10.1016\/j.ajo.2026.06.002_bib0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ophtha.2024.02.023","article-title":"Assessment of visual function with Cotoretigene Toliparvovec in X-linked retinitis pigmentosa in the randomized XIRIUS phase 2\/3 study","volume":"131","author":"Lam","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.06.002_bib0016","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. 2025. Available from https:\/\/www.R-project.org\/"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.10.2.28","article-title":"Low luminance visual acuity and Low luminance deficit in choroideremia and RPGR-associated retinitis pigmentosa","volume":"10","author":"Wood","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.002_bib0018","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/ceo.13753","article-title":"Test-retest repeatability of microperimetry in patients with retinitis pigmentosa caused by mutations in RPGR","volume":"48","author":"Buckley","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.10.7.12","article-title":"Microperimetry hill of vision and volumetric measures of retinal sensitivity","volume":"10","author":"Josan","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-097970","article-title":"Functional vision tests as clinical trial outcome measures in ophthalmology: a scoping review","volume":"15","author":"Raji","year":"2025","journal-title":"BMJ Open"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:33:11Z","timestamp":1788280391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426003028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"alternative-id":["S0002939426003028"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.002","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microperimetry as an Outcome Measure Improves Patient Eligibility and Efficacy Detection in RPGR Gene Therapy Trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}